DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C1842836 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0025958 | Microcephaly | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0005695 | Bladder Neoplasm | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C3714756 | Intellectual Disability | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0038273 | Stereotypic Movement Disorder | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0013384 | Dyskinetic syndrome | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0020490 | Hyperopia | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0005684 | Malignant neoplasm of urinary bladder | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C3280127 | MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15 | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0036572 | Seizures | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0282577 | Congenital Disorders of Glycosylation | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0242172 | Pelvic Inflammatory Disease | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C2239176 | Liver carcinoma | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0699885 | Carcinoma of bladder | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0751495 | Seizures, Focal | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0039075 | Syndactyly | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0006826 | Malignant Neoplasms | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0036857 | Severe intellectual disability | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0520947 | Clumsiness - motor delay | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0008489 | Chorea | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0235946 | Cerebral atrophy | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0004352 | Autistic Disorder | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C1868720 | Periventricular Nodular Heterotopia | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C1527366 | Salaam Seizures | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0221757 | alpha 1-Antitrypsin Deficiency | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024